NCT02495675

Brief Summary

This study evaluates the work of breathing among healthy subjects under various conditions of treatment with high flow nasal cannulas. Ten subjects will be included. The design of this study is a cross over of five treatment periods with different flow settings.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 13, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Last Updated

July 13, 2015

Status Verified

July 1, 2015

Enrollment Period

4 months

First QC Date

June 4, 2015

Last Update Submit

July 10, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Work of breathing

    Work of breathing at the end of each period is calculated from the measurement of esophageal pressure and tidal volume (composite outcome).

    10 minutes

Secondary Outcomes (9)

  • Esophageal pressure-time product

    10 minutes

  • Tidal Volume

    10 minutes

  • Comfort of breathing

    10 minutes

  • Blood gases

    10 minutes

  • Dyspnea

    10 minutes

  • +4 more secondary outcomes

Study Arms (5)

No flow

NO INTERVENTION

Subjects will be spontaneously breathing in room air with no flow.

Conventional flow via nasal prongs

EXPERIMENTAL

Subjects will be breathing with nasal prongs delivering 5 L/min of air (inspired fraction of oxygen: 0.21)

Device: Conventional flow via nasal prongs

High flow nasal cannulas 20 L/min

EXPERIMENTAL

Subjects will be breathing with high flow nasal cannulas delivering 20 L/min with an inspired fraction of oxygen of 0.21.

Device: High flow nasal cannulas

High flow nasal cannulas 40 L/min

EXPERIMENTAL

Subjects will be breathing with high flow nasal cannulas delivering 40 L/min with an inspired fraction of oxygen of 0.21.

Device: High flow nasal cannulas

High flow nasal cannulas 60 L/min

EXPERIMENTAL

Subjects will be breathing with high flow nasal cannulas delivering 60 L/min with an inspired fraction of oxygen of 0.21.

Device: High flow nasal cannulas

Interventions

Comparison of different flow levels

Also known as: Airvo 2; Ficher and Paykel HealthCare
High flow nasal cannulas 20 L/minHigh flow nasal cannulas 40 L/minHigh flow nasal cannulas 60 L/min

Low flow of air delivered through conventional nasal prongs

Conventional flow via nasal prongs

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy subjects
  • Written and informed consent

You may not qualify if:

  • Pregnant or breastfeeding women;
  • Subject enrolled in another study excluding co-enrolment;
  • Cardio-vascular or respiratory disease;
  • History of ear nose and throat disease (i.e. surgery, epistaxis, trauma), eso-gastric disease (i.e. esophageal varices, digestive haemorrhage), rheumatologic or neurologic disease possibly interfering with the design of the study;
  • Subject feeling nauseous or under recent fed condition (\<1h).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de Recherche de l'IUCPQ

Québec, Quebec, G1V4G5, Canada

RECRUITING

Related Publications (1)

  • Delorme M, Bouchard PA, Simon M, Simard S, Lellouche F. Physiologic Effects of High-Flow Nasal Cannula in Healthy Subjects. Respir Care. 2020 Sep;65(9):1346-1354. doi: 10.4187/respcare.07306. Epub 2020 Apr 14.

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • François Lellouche, MD, PhD

    Fondation IUCPQ

    STUDY DIRECTOR

Central Study Contacts

Mathieu Delorme, PT, MSc

CONTACT

François Lellouche, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2015

First Posted

July 13, 2015

Study Start

June 1, 2015

Primary Completion

October 1, 2015

Last Updated

July 13, 2015

Record last verified: 2015-07

Locations